VitaNova Life Sciences VNOV
OTC VNOV
$1.38 +0.00 (+0.00%)
At close: Sep 16, 2026 · 4:00 PM EDT

VitaNova Life Sciences (VNOV) Liabilities from Discontinued Operations (2018)

VitaNova Life Sciences' (VNOV) quarterly Liabilities from Discontinued Operations came in at $5600.0 in Q2 2018.

Analysis

VitaNova Life Sciences (VNOV) Liabilities from Discontinued Operations (2018) Analysis & Trends

VitaNova Life Sciences has disclosed Liabilities from Discontinued Operations across 1 years of filings, most recently posting $5600.0 for Q2 2018.

  • Liabilities from Discontinued Operations for Q2 2018 came in at $5600.0, changed N/A year-over-year; the trailing twelve-month figure through Apr 2018 was $5600.0 (changed N/A YoY), and the FY2018 annual result was $5600.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations for Q2 2018 stood at $5600.0.
  • Across five years, Liabilities from Discontinued Operations topped out at $5600.0 in Q2 2018 and bottomed at $5600.0 in Q2 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Accenture 120.96 Bn 111.91 Bn 6.13 Bn
2 UL Solutions 12.94 Bn 12.53 Bn 417.00 Mn
3 Gartner 11.74 Bn 10.25 Bn 1.19 Bn
4 Booz Allen Hamilton Holding 9.28 Bn 8.74 Bn 1.46 Bn
5 Tetra Tech 9.14 Bn 8.91 Bn 243.21 Mn
6 Genpact 5.74 Bn 5.22 Bn 490.34 Mn
7 Grand Canyon Education 3.97 Bn 3.69 Bn 204.08 Mn
8 Fti Consulting 3.91 Bn 3.74 Bn 316.27 Mn
9 Korn Ferry 3.90 Bn 3.09 Bn 681.29 Mn
10 VitaNova Life Sciences 11.51 Mn 9.90 Mn 30,521.00
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2018 5,600.00